Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank

Breast Cancer Research

Volumn 16, Issue 2, 2014, Pages

  Pardo, Ivanesa ^b   Lillemoe, Heather A ^b   Blosser, Rachel J ^b   Choi, MiRan ^a   Sauder, Candice A M ^b   Doxey, Diane K ^b   Mathieson, Theresa ^c   Hancock, Bradley A ^b   Baptiste, Dadrie ^b   Atale, Rutuja ^b   Hickenbotham, Matthew ^d   Zhu, Jin ^d   Glasscock, Jarret ^d   Storniolo, Anna Maria V ^b,c   Zheng, Faye ^e   Doerge, RW ^e   Liu, Yunlong ^b   Badve, Sunil ^b   Radovich, Milan ^b   Clare, Susan E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Medicine Indiana University School of Medicine ^*  (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOM SYNDROME HELICASE; BRCA1 PROTEIN; CHECKPOINT KINASE 1; CONTRACEPTIVE AGENT; DNA; ESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; FANCONI ANEMIA PROTEIN; MESSENGER RNA; NORETHISTERONE; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; RAD51 PROTEIN; RAD54 PROTEIN; STROMELYSIN; TRANSCRIPTOME; WNT4 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME SEGREGATION; CYTOKINESIS; DEVELOPMENTAL GENETICS; DNA DAMAGE; DNA REPLICATION; DNA REPLICATION ORIGIN; EXCISION REPAIR; FEMALE; FOLLICULAR PHASE; GENETIC CODE; HEALTH CARE FACILITY; HOMOLOGOUS RECOMBINATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; LUTEAL PHASE; MAMMARY GLAND; MEMBRANE TRANSPORT; MENSTRUAL CYCLE; MIDDLE AGED; MITOSIS; NORMAL HUMAN; NUCLEAR DIVISION; NUCLEOTIDE METABOLISM; PARACRINE SIGNALING; PREMENOPAUSE; PROTEIN EXPRESSION; RNA SEQUENCE; SEQUENCE ANALYSIS; YOUNG ADULT; ALGORITHM; BREAST; EPITHELIUM; GENE REGULATORY NETWORK; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL;

ADULT; ALGORITHMS; BREAST; EPITHELIUM; FEMALE; FOLLICULAR PHASE; GENE REGULATORY NETWORKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LINEAR MODELS; LUTEAL PHASE; MIDDLE AGED; PREMENOPAUSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE BANKS; TRANSCRIPTOME;

EID: 84897992516     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3627     Document Type: Article

References (101)

1. Charting the Course: Priorities for Breast Cancer. Research Report of the Breast Cancer Progress Review Group. [http://planning.cancer.gov/library/1998breastcancer.pdf].
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
3. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 2005, 97:1652-1662. 10.1093/jnci/dji372, 16288118.
4. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388. 10.1093/jnci/90.18.1371, 9747868.
5. Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, Hamed A, Howell A, Powles T. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002, 360:817-824.
6. Cuzick J, Forbes JF, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A. Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 2007, 99:272-282. 10.1093/jnci/djk049, 17312304.
7. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006, 295:2727-2741. 10.1001/jama.295.23.joc60074, 16754727.
8. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N. Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res (Phila) 2010, 3:696-706. 10.1158/1940-6207.CAPR-10-0076, 2935331, 20404000.
9. Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 2011, 364:2381-2391. 10.1056/NEJMoa1103507, 21639806.
10. Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM. The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the " molecular histology" of the breast. Cancer Prev Res (Phila) 2012, 5:528-535. 10.1158/1940-6207.CAPR-11-0234, 22345117.
11. Strange R, Westerlind KC, Ziemiecki A, Andres AC. Proliferation and apoptosis in mammary epithelium during the rat oestrous cycle. Acta Physiol (Oxf) 2007, 190:137-149. 10.1111/j.1748-1716.2007.01704.x, 17433024.
12. Schedin P, Mitrenga T, Kaeck M. Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague-Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 2000, 5:211-225. 10.1023/A:1026447506666, 11149574.
13. Vogel PM, Georgiade NG, Fetter BF, Vogel FS, McCarty KS. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 1981, 104:23-34. 1903738, 7258295.
14. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15:17-35.
15. Anderson TJ, Ferguson DJ, Raab GM. Cell turnover in the " resting" human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982, 46:376-382. 10.1038/bjc.1982.213, 2011125, 7126427.
16. Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the " resting" human breast. Br J Cancer 1981, 44:177-181. 10.1038/bjc.1981.168, 2010743, 7272186.
17. Navarrete MA, Maier CM, Falzoni R, Quadros LG, Lima GR, Baracat EC, Nazario AC. Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res: BCR 2005, 7:R306-R313.
18. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802. 10.1038/nature09027, 20383121.
19. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807. 10.1038/nature09091, 20445538.
20. Wood PA, Hrushesky WJ. Sex cycle modulates cancer growth. Breast Cancer Res Treat 2005, 91:95-102. 10.1007/s10549-005-8269-6, 15868436.
21. Paradiso A, Serio G, Fanelli M, Mangia A, Cellamare G, Schittulli F. Predictability of monthly and yearly rhythms of breast cancer features. Breast Cancer Res Treat 2001, 67:41-49. 10.1023/A:1010658804640, 11518465.
22. Coradini D, Veneroni S, Pellizzaro C, Daidone MG. Fluctuation of intratumor biological variables as a function of menstrual timing of surgery for breast cancer in premenopausal patients. Ann Oncol 2003, 14:962-964.
23. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, Hao L, Kiang A, Paschall J, Phan L, Popova N, Pretel S, Ziyabari L, Lee M, Shao Y, Wang ZY, Sirotkin K, Ward M, Kholodov M, Zbicz K, Beck J, Kimelman M, Shevelev S, Preuss D, Yaschenko E, Graeff A, Ostell J, Sherry ST. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 2007, 39:1181-1186. 2031016, 17898773.
24. The Database of Genotypes and Phenotypes (dgGaP). [http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap].
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 1995, 57:289-300.
26. Ingenuity Pathway Analysis. [http://www.ingenuity.com].
27. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
28. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13. 10.1093/nar/gkn923, 2615629, 19033363.
29. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002, 13:1977-2000. 10.1091/mbc.02-02-0030., 117619, 12058064.
30. Bar-Joseph Z, Siegfried Z, Brandeis M, Brors B, Lu Y, Eils R, Dynlacht BD, Simon I. Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells. Proc Natl Acad Sci U S A 2008, 105:955-960. 10.1073/pnas.0704723105, 2242708, 18195366.
31. Pena-Diaz J, Hegre SA, Anderssen E, Aas PA, Mjelle R, Gilfillan GD, Lyle R, Drablos F, Krokan HE, Saetrom P. Transcription profiling during the cell cycle shows that a subset of Polycomb-targeted genes is upregulated during DNA replication. Nucleic Acids Res 2013, 41:2846-2856. 10.1093/nar/gks1336, 3597645, 23325852.
32. Grant GD, Brooks L, Zhang X, Mahoney JM, Martyanov V, Wood TA, Sherlock G, Cheng C, Whitfield ML. Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors. Mole Biol Cell 2013, 24:3634-3650.
33. Bryant JA, Aves SJ. Initiation of DNA replication: functional and evolutionary aspects. Ann Bot 2011, 107:1119-1126. 10.1093/aob/mcr075, 3091809, 21508040.
34. Ma HT, Tsang YH, Marxer M, Poon RY. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol Cell Biol 2009, 29:6500-6514. 10.1128/MCB.00669-09, 2786869, 19822658.
35. Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 2005, 7:195-201. 10.1038/ncb1212, 15665856.
36. Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, Wahrer DC, Sgroi DC, Lane WS, Haber DA, Livingston DM. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 2001, 105:149-160. 10.1016/S0092-8674(01)00304-X, 11301010.
37. Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Sole X, Hernandez P, Lazaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Offit K, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338-1349. 10.1038/ng.2007.2, 17922014.
38. Hogg M, Sauer-Eriksson AE, Johansson E. Promiscuous DNA synthesis by human DNA polymerase θ. Nucleic Acids Res 2012, 40:2611-2622. 10.1093/nar/gkr1102, 3315306, 22135286.
39. McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'Connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 2006, 66:8109-8115. 10.1158/0008-5472.CAN-06-0140, 16912188.
40. Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA, Seachrist JL. The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Res 2000, 60:936-943.
41. Eigeliene N, Elo T, Linhala M, Hurme S, Erkkola R, Harkonen P. Androgens inhibit the stimulatory action of 17beta-estradiol on normal human breast tissue in explant cultures. J Clin Endocrinol Metab 2012, 97:E1116-E1127. 10.1210/jc.2011-3228, 22535971.
42. Martinez-Giner M, Noguera JL, Balcells I, Alves E, Varona L, Pena RN. Expression study on the porcine PTHLH gene and its relationship with sow teat number. J Anim Breed Genet 2011, 128:344-353. 10.1111/j.1439-0388.2011.00925.x, 21906180.
43. Martello G, Sugimoto T, Diamanti E, Joshi A, Hannah R, Ohtsuka S, Gottgens B, Niwa H, Smith A. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell 2012, 11:491-504. 10.1016/j.stem.2012.06.008, 3465555, 23040478.
44. Festuccia N, Osorno R, Halbritter F, Karwacki-Neisius V, Navarro P, Colby D, Wong F, Yates A, Tomlinson SR, Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490. 10.1016/j.stem.2012.08.002, 3473361, 23040477.
45. Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab 2011, 13:139-148. 10.1016/j.cmet.2011.01.005, 3072597, 21284981.
46. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693. 10.1083/jcb.125.3.681, 2119999, 8175886.
47. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001, 128:3117-3131. 2785713, 11688561.
48. Hsieh CW, Huang C, Bederman I, Yang J, Beidelschies M, Hatzoglou M, Puchowicz M, Croniger CM. Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells. J Lipid Res 2011, 52:1352-1362. 10.1194/jlr.M012666, 3122918, 21504969.
49. Hsieh CW, Millward CA, DeSantis D, Pisano S, Machova J, Perales JC, Croniger CM. Reduced milk triglycerides in mice lacking phosphoenolpyruvate carboxykinase in mammary gland adipocytes and white adipose tissue contribute to the development of insulin resistance in pups. J Nutr 2009, 139:2257-2265. 10.3945/jn.109.113092, 2777474, 19812223.
50. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 2010, 129:207-219. 10.1111/j.1365-2567.2009.03165.x, 2814463, 19824918.
51. Graham JD, Mote PA, Salagame U, van Dijk JH, Balleine RL, Huschtscha LI, Reddel RR, Clarke CL. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 2009, 150:3318-3326. 10.1210/en.2008-1630, 2703536, 19342456.
52. Yin P, Roqueiro D, Huang L, Owen JK, Xie A, Navarro A, Monsivais D, Coon JS, Kim JJ, Dai Y, Bulun SE. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. PloS One 2012, 7:e29021. 10.1371/journal.pone.0029021, 3260146, 22272226.
53. Moore MR, Zhou JL, Blankenship KA, Strobl JS, Edwards DP, Gentry RN. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mole Biol 1997, 62:243-252.
54. Leung JY, Ehmann GL, Giangrande PH, Nevins JR. A role for Myc in facilitating transcription activation by E2F1. Oncogene 2008, 27:4172-4179. 10.1038/onc.2008.55, 18345030.
55. Wong JV, Dong P, Nevins JR, Mathey-Prevot B, You L. Network calisthenics: control of E2F dynamics in cell cycle entry. Cell Cycle 2011, 10:3086-3094. 10.4161/cc.10.18.17350, 3218619, 21900750.
56. Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv Cancer Res 2013, 118:97-398.
57. Millour J, de Olano N, Horimoto Y, Monteiro LJ, Langer JK, Aligue R, Hajji N, Lam EW. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther 2011, 10:1046-1058. 10.1158/1535-7163.MCT-11-0024, 21518729.
58. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J Biol Chem 2002, 277:21971-21982. 10.1074/jbc.M200434200, 11923298.
59. Bergamaschi A, Christensen BL, Katzenellenbogen BS. Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3zeta, FOXM1, and a gene signature associated with mitosis. BCR 2011, 13:R70. 10.1186/bcr2913, 3218959, 21707964.
60. Carr JR, Park HJ, Wang Z, Kiefer MM, Raychaudhuri P. FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 2010, 70:5054-5063. 10.1158/0008-5472.CAN-10-0545, 2893542, 20530690.
61. McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS, Krol J, Kwok JM, Polychronis A, Coombes RC, Lam EW. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mole Cancer Ther 2009, 8:582-591.
62. Francis RE, Myatt SS, Krol J, Hartman J, Peck B, McGovern UB, Wang J, Guest SK, Filipovic A, Gojis O, Palmieri C, Peston D, Shousha S, Yu Q, Sicinski P, Coombes RC, Lam EW. FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol 2009, 35:57-68. 3065068, 19513552.
63. Kwok JM, Peck B, Monteiro LJ, Schwenen HD, Millour J, Coombes RC, Myatt SS, Lam EW. FOXM1 confers acquired cisplatin resistance in breast cancer cells. MCR 2010, 8:24-34. 10.1158/1541-7786.MCR-09-0432, 2809047, 20068070.
64. Sambasivan R, Cheedipudi S, Pasupuleti N, Saleh A, Pavlath GK, Dhawan J. The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter. J Cell Sci 2009, 122:3481-3491. 10.1242/jcs.048678, 2746131, 19723804.
65. Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O. Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status. Int J Cancer 2005, 117:730-737. 10.1002/ijc.21221, 15957166.
66. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 1998, 95:5076-5081. 10.1073/pnas.95.9.5076, 20216, 9560231.
67. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000, 14:650-654. 316462, 10733525.
68. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, Choi Y, Schneider P, Brisken C. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A 2010, 107:2989-2994. 10.1073/pnas.0915148107, 2840294, 20133621.
69. Axlund SD, Sartorius CA. Progesterone regulation of stem and progenitor cells in normal and malignant breast. Mol Cell Endocrinol 2012, 357:71-79. 10.1016/j.mce.2011.09.021, 3288619, 21945473.
70. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K, Hashimoto K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000, 275:5748-5753. 10.1074/jbc.275.8.5748, 10681561.
71. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 2005, 146:77-84. 10.1210/en.2004-0588, 15459120.
72. Garland M, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Spiegelman D, Speizer F, Willett WC. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 1998, 147:636-643. 10.1093/oxfordjournals.aje.a009504, 9554602.
73. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397.
74. Sidorova JM, Breeden LL. Precocious G1/S transitions and genomic instability: the origin connection. Mutat Res 2003, 532:5-19. 10.1016/j.mrfmmm.2003.08.006, 14643425.
75. Pike MC, Spicer DV. Hormonal contraception and chemoprevention of female cancers. Endocr Relat Cancer 2000, 7:73-83. 10.1677/erc.0.0070073, 10903525.
76. Cheeseman IM, Desai A. Molecular architecture of the kinetochore-microtubule interface. Nat Rev Mol Cell Biol 2008, 9:33-46. 10.1038/nrm2310, 18097444.
77. Higgins J, Midgley C, Bergh AM, Bell SM, Askham JM, Roberts E, Binns RK, Sharif SM, Bennett C, Glover DM, Woods CG, Morrison EE, Bond J. Human ASPM participates in spindle organisation, spindle orientation and cytokinesis. BMC Cell Biol 2010, 11:85. 10.1186/1471-2121-11-85, 2988714, 21044324.
78. Labit H, Fujimitsu K, Bayin NS, Takaki T, Gannon J, Yamano H. Dephosphorylation of Cdc20 is required for its C-box-dependent activation of the APC/C. EMBO J 2012, 31:3351-3362. 10.1038/emboj.2012.168, 3411074, 22713866.
79. Raiborg C, Stenmark H. Cell biology. A helix for the final cut. Science 2011, 331:1533-1534. 10.1126/science.1204208, 21436431.
80. Gai M, Camera P, Dema A, Bianchi F, Berto G, Scarpa E, Germena G, Di Cunto F. Citron kinase controls abscission through RhoA and anillin. Mole Biol Cell 2011, 22:3768-3778.
81. Cheng L, Zhang J, Ahmad S, Rozier L, Yu H, Deng H, Mao Y. Aurora B regulates formin mDia3 in achieving metaphase chromosome alignment. Dev Cell 2011, 20:342-352. 10.1016/j.devcel.2011.01.008, 21397845.
82. Ye F, Tan L, Yang Q, Xia Y, Deng LW, Murata-Hori M, Liou YC. HURP regulates chromosome congression by modulating kinesin Kif18A function. Curr Biol 2011, 21:1584-1591. 10.1016/j.cub.2011.08.024, 21924616.
83. Su KC, Takaki T, Petronczki M. Targeting of the RhoGEF Ect2 to the equatorial membrane controls cleavage furrow formation during cytokinesis. Dev Cell 2011, 21:1104-1115. 10.1016/j.devcel.2011.11.003, 22172673.
84. Rouzeau S, Cordelieres FP, Buhagiar-Labarchede G, Hurbain I, Onclercq-Delic R, Gemble S, Magnaghi-Jaulin L, Jaulin C, Amor-Gueret M. Bloom's syndrome and PICH helicases cooperate with topoisomerase IIalpha in centromere disjunction before anaphase. PloS One 2012, 7:e33905. 10.1371/journal.pone.0033905, 3338505, 22563370.
85. Sun Y, Kucej M, Fan HY, Yu H, Sun QY, Zou H. Separase is recruited to mitotic chromosomes to dissolve sister chromatid cohesion in a DNA-dependent manner. Cell 2009, 137:123-132. 10.1016/j.cell.2009.01.040, 2673135, 19345191.
86. Matsuo K, Ohsumi K, Iwabuchi M, Kawamata T, Ono Y, Takahashi M. Kendrin is a novel substrate for separase involved in the licensing of centriole duplication. Curr Biol 2012, 22:915-921. 10.1016/j.cub.2012.03.048, 22542101.
87. Moshe Y, Bar-On O, Ganoth D, Hershko A. Regulation of the action of early mitotic inhibitor 1 on the anaphase-promoting complex/cyclosome by cyclin-dependent kinases. J Biol Chem 2011, 286:16647-16657. 10.1074/jbc.M111.223339, 3089507, 21454540.
88. Kais Z, Barsky SH, Mathsyaraja H, Zha A, Ransburgh DJ, He G, Pilarski RT, Shapiro CL, Huang K, Parvin JD. KIAA0101 interacts with BRCA1 and regulates centrosome number. MCR 2011, 9:1091-1099. 10.1158/1541-7786.MCR-10-0503, 3157549, 21673012.
89. Tada K, Susumu H, Sakuno T, Watanabe Y. Condensin association with histone H2A shapes mitotic chromosomes. Nature 2011, 474:477-483. 10.1038/nature10179, 21633354.
90. Heale JT, Ball AR, Schmiesing JA, Kim JS, Kong X, Zhou S, Hudson DF, Earnshaw WC, Yokomori K. Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair. Mol Cell 2006, 21:837-848. 10.1016/j.molcel.2006.01.036, 16543152.
91. Verbakel W, Carmeliet G, Engelborghs Y. SAP-like domain in nucleolar spindle associated protein mediates mitotic chromosome loading as well as interphase chromatin interaction. Biochem Biophys Res Commun 2011, 411:732-737. 10.1016/j.bbrc.2011.07.015, 21782797.
92. Park JH, Nishidate T, Nakamura Y, Katagiri T. Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci 2010, 101:403-411. 10.1111/j.1349-7006.2009.01400.x, 19900192.
93. Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T, Fukunaga R. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 1998, 2:877-885. 10.1016/S1097-2765(00)80302-0, 9885575.
94. Shrestha S, Wilmeth LJ, Eyer J, Shuster CB. PRC1 controls spindle polarization and recruitment of cytokinetic factors during monopolar cytokinesis. Mole Biol Cell 2012, 23:1196-1207.
95. Niiya F, Xie X, Lee KS, Inoue H, Miki T. Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner. J Biol Chem 2005, 280:36502-36509. 10.1074/jbc.M508007200, 16118207.
96. Zhao WM, Fang G. MgcRacGAP controls the assembly of the contractile ring and the initiation of cytokinesis. Proc Natl Acad Sci U S A 2005, 102:13158-13163. 10.1073/pnas.0504145102, 1201590, 16129829.
97. Wang X, Yang Y, Duan Q, Jiang N, Huang Y, Darzynkiewicz Z, Dai W. sSgo1, a major splice variant of Sgo1, functions in centriole cohesion where it is regulated by Plk1. Dev Cell 2008, 14:331-341. 10.1016/j.devcel.2007.12.007, 2279080, 18331714.
98. Jeyaprakash AA, Santamaria A, Jayachandran U, Chan YW, Benda C, Nigg EA, Conti E. Structural and functional organization of the Ska complex, a key component of the kinetochore-microtubule interface. Mol Cell 2012, 46:274-286. 10.1016/j.molcel.2012.03.005, 22483620.
99. Manning AL, Bakhoum SF, Maffini S, Correia-Melo C, Maiato H, Compton DA. CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity. EMBO J 2010, 29:3531-3543. 10.1038/emboj.2010.230, 2964175, 20852589.
100. Larsson N, Marklund U, Gradin HM, Brattsand G, Gullberg M. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 1997, 17:5530-5539. 232401, 9271428.
101. Hsieh CL, Lin CL, Liu H, Chang YJ, Shih CJ, Zhong CZ, Lee SC, Tan BC. WDHD1 modulates the post-transcriptional step of the centromeric silencing pathway. Nucleic Acids Res 2011, 39:4048-4062. 10.1093/nar/gkq1338, 3105424, 21266480.